A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis
Clinical trial NCT04626921 · COMPLETED
Trial details
- NCT number
- NCT04626921
- Sponsor
- Clene Nanomedicine
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-22
- Primary completion
- 2023-05-29
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.